| 注册
首页|期刊导航|中国临床药理学杂志|中药调控AGE-RAGE信号通路治疗多囊卵巢综合征的研究现状

中药调控AGE-RAGE信号通路治疗多囊卵巢综合征的研究现状

冉冰清 黄进格 吴月娟 王芳

中国临床药理学杂志2024,Vol.40Issue(17):2596-2600,5.
中国临床药理学杂志2024,Vol.40Issue(17):2596-2600,5.DOI:10.13699/j.cnki.1001-6821.2024.17.029

中药调控AGE-RAGE信号通路治疗多囊卵巢综合征的研究现状

Research progress of Chinese medicine regulating AGE-RAGE signaling pathway in the treatment of polycystic ovary syndrome

冉冰清 1黄进格 1吴月娟 1王芳2

作者信息

  • 1. 甘肃中医药大学中西医结合临床医学院,甘肃兰州 730000
  • 2. 兰州大学第二医院生殖医学科,甘肃兰州 730030
  • 折叠

摘要

Abstract

Polycystic ovary syndrome(PCOS)is a common endocrine and metabolic disease in gynecology.The main clinical manifestations are infertility,hirsuty,obesity,menstrual disorders,etc.,which seriously affect women's health.Studies have shown that the mechanism of action of traditional Chinese medicine in the treatment of PCOS involves a variety of signaling pathways,among which advanced glycation end products-receptor for advanced glycation end products(AGE-RAGE)signaling pathway is an important pathway regulating inflammation and oxidative stress.More and more Chinese herbal compounds,single herbs and their extracts can reduce inflammation,oxidative stress,insulin resistance and hyperandrogenemia in patients by regulating AGE-RAGE signaling pathway,which provides a new strategy and direction for the treatment of PCOS.However,there is currently no comprehensive summary of Chinese medicine intervention in the treatment of PCOS by AGE-RAGE signaling pathway.Therefore,this paper reviews the current research status of Chinese medicine regulation of AGE-RAGE signaling pathway in the treatment of PCOS in recent years,so as to provide new directions and thoughts for further research on PCOS.

关键词

中药/多囊卵巢综合征/晚期糖基化终产物-晚期糖基化终末产物受体信号通路/治疗

Key words

traditional Chinese medicine/polycystic ovary syndrome/advanced glycation end products-receptor for advanced glycation end products signaling pathway/treatment

分类

医药卫生

引用本文复制引用

冉冰清,黄进格,吴月娟,王芳..中药调控AGE-RAGE信号通路治疗多囊卵巢综合征的研究现状[J].中国临床药理学杂志,2024,40(17):2596-2600,5.

基金项目

兰州大学第二医院"萃英科技创新"基金资助项目(CY2022-MSB03) (CY2022-MSB03)

中国临床药理学杂志

OA北大核心CSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文